InCytokine, an Open-Source Software, Reveals a TREM2 Variant-Specific Cytokine Signature
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031137 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Deepak Jha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Data and Genome Sciences, Merck & Co., Inc., Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Receptors, Immunologic, Membrane Glycoproteins, Cytokines, Software. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cytokine and chemokine profiling is central to understanding inflammatory processes and the mechanisms driving diverse diseases. We introduce InCytokine, an open-source tool for semiquantitative analysis of cytokine and chemokine data generated by protein array technologies. InCytokine features robust and modular image-processing workflows, including automated spot detection, template alignment, normalization, quality control measures, and quantitative intensity summarization to deliver consistent and reliable readouts from profiling assays. We evaluated InCytokine by profiling wild-type microglia, TREM2 knockout, and Alzheimer’s disease-associated TREM2 R47H variant cells in response to lipopolysaccharide and sulfatide exposure. Differential expression analysis revealed unique sulfatide-specific and genotype-specific cytokine signatures in TREM2 variants. We also report an intriguing modulation of DPP4 and a divergent expression pattern of ENA-78 in TREM2 variants in response to lipopolysaccharide and sulfatide treatment. Such distinct expression signatures raise the possibility that TREM2 variants may play a role in modulating inflammatory signaling relevant to cardio-metabolic and Alzheimer’s disease. These signatures were corroborated using transcriptional profiling of the same microglia cells, revealing also a good concordance between protein array and RNA sequencing technologies. Taken together, InCytokine is an interactive, user-friendly web application for rapid, reproducible, and scalable analysis of protein array data, proven to generate meaningful insights for drug and biomarker discovery campaigns in pharmaceutical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Data and Genome Sciences, Merck & Co., Inc., Boston, MA 02115, USA.
- Applied Research and Innovation, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic.
- Data Science and Scientific Informatics, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic.
ORCID-Profile: Deepak Jha, Marco Ancona, Danny A Bitton
Zitieren
APA
Jha, D., Ancona, M., Oplt, F., Farmer, S. L., Vagenknecht, M., Vazquez-Otero, A., Prazdnyk, I., Soukup, J., Mathew, R. S., Peterson, V., & Bitton, D. A. (2026). InCytokine, an Open-Source Software, Reveals a TREM2 Variant-Specific Cytokine Signature. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031137
Vancouver
Jha D, Ancona M, Oplt F, Farmer SL, Vagenknecht M, Vazquez-Otero A, et al. InCytokine, an Open-Source Software, Reveals a TREM2 Variant-Specific Cytokine Signature. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031137
BibTeX
@article{Jha2026,
author = {Jha, Deepak and Ancona, Marco and Oplt, Filip and Farmer, Sonia L and Vagenknecht, Martin and Vazquez-Otero, Alejandro and Prazdnyk, Illia and Soukup, Jindrich and Mathew, Rebecca S and Peterson, Vanessa and Bitton, Danny A},
title = {InCytokine, an Open-Source Software, Reveals a TREM2 Variant-Specific Cytokine Signature},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031137}
}
EUVIMED